BlueTech Media LLP

The 5th Edition of the India Biopharma Leaders Conclave has the theme "New Horizons in Biopharma, Biosimilars, & Biologics." This theme likely indicates a focus on exploring new frontiers and opportunities in the biopharmaceutical industry, particularly in the areas of biosimilars and biologics. The conclave may feature discussions and presentations on advancements in biopharmaceutical R&D regulatory updates, market trends, and the latest innovations in the development and manufacturing of biosimilar and biologic products. It could also address challenges and opportunities in these sectors, such as improving access to affordable biopharmaceuticals and ensuring quality and safety standards.

Join us with renowned speakers and eminent leaders from around the world for the conference as we exaggerate the present to imagine a future where biopharma isn't just a field of study but a journey of discovery that holds the promise of transforming millions of lives.

Why Attend

☑️ Gain valuable insights into the evolving landscape of the biopharma industry, including the impact of innovations, regulatory changes, and compliance challenges

☑️ Emphasize the opportunities for making connections with industry peers, potential collaborators to expand your professional network.

☑️ Discover new products, services, and technologies that are driving innovation in the biopharma sector.

☑️ Participate in a forum that encourages the exchange of knowledge and ideas, fostering collaborations that could shape the trajectory of the industry.

☑️ Discuss the challenges faced by the biopharma industry, including regulatory hurdles, research and development complexities, market competition, and ethical considerations.

Key Topics

A glimpse into the next wave of biosimilars: future and challenges
Understanding the success rates and challenges faced during the development of new R&D in biosimilars.

Biosimilars adhere to the same standards of quality, safety, and efficacy as all biological medicines.
The future of cell and gene therapy manufacturing.

Explore why robust quality standards are crucial for biologics and biosimilars.
Delve into emerging trends and technologies in quality assurance for biologics.

Digitalized supply chains are essential to biopharma's future.
The Crucial Role of a Digital Backbone in the Biopharma Industry

Reflects a growing trend of consolidation in the biopharma industry.
Advances and Barriers to Driving the Future of CAR-T Cell Therapies.

Esteemed Speakers

Dr. Ashok Kumar Patra,

Director, Biologics Development,

Imgenex India Pvt. Ltd

Dr. Kripa Murzello,

Assistant Vice President, Head R&D Biologicals, Bharat Serum & Vaccines Ltd

Dr. Shubhadeep Sinha,

Senior VP Medical Director & Head Clinical Development /Medical Affairs, Hetero Group

Dr. Kishore J.R. Kunapuli,

Chief Scientific Officer- Cell Therapy Division,

Pulse Pharmaceuticals Pvt. Ltd

Dr. Arun Shastry,

Chief Scientific Officer

Dystrophy Annihilation Research Trust

Dr. Murali K Addepalli,

CSO, Lextro Bio

Mr. Mannan Khambati,

AVP Biotech Production, Bharat Serums and Vaccines Limited

Dr. Vishwottam Kandikere,

PhD, Research Director & Head of DMPK, Syngene International Limited

Mr. Mukesh Patale,

Head of USP MSAT-Biosimilars and Biologics (Mabs),

Dr. Reddy's Laboratories

Dr. Anurag Tiwari,

AVP, R&D,

Zumutor Biologics Pvt. Ltd.

Register Now

Why Attend

Event Highlights

Key Topics

Advisory Board

Esteemed Speakers

Presenting Partner

Associate Partner

Exhibit Partner

Media Partner

Register Now

Why Attend

Event Highlights

Key Topics

Advisory Board

Esteemed Speakers

Presenting Partner

Associate Partner

Exhibit Partner

Media Partner

This website uses cookies.